ArticlePharmaceuticals (Basel, Switzerland)2023

NMDA Receptor Glycine Binding Site Modulators for Prevention and Treatment of Ketamine Use Disorder.

Yu-Chin Hsiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.